Real-time enrollment status for this philadelphia chromosome-positive clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 6:24 AM UTC
| NCT Number | NCT06308588 |
| Recruiting Status | Recruiting |
| Condition | Philadelphia Chromosome-Positive |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 2 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | October 13, 2026 (2 days ago) |
As of October 15, 2026: Clinical trial NCT06308588 is currently recruiting participants. This phase1 study for philadelphia chromosome-positive is actively seeking new participants at 2 locations across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06308588 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06308588 was last updated 2 days ago (October 13, 2026). HelloStudys verifies this status automatically.